We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA CHIEF ASKS FOR DELAY OF SENATE ANTIDEPRESSANT PROBE
FDA CHIEF ASKS FOR DELAY OF SENATE ANTIDEPRESSANT PROBE
August 13, 2004
The FDA wants the U.S. senator leading an investigation into the possible suppression of study results linking antidepressant use and pediatric suicide to delay interrogating agency employees until after the FDA has completely investigated the matter.